Results 191 to 200 of about 16,013 (232)
Some of the next articles are maybe not open access.
Imaging of Chronic Kidney Disease—Mineral and Bone Disorder
Radiologic Clinics of North America, 2022The characteristic radiological appearances of metabolic bone and soft tissue diseases in chronic renal failure are described and illustrated in the context of advancing understanding of the complex metabolic changes that occur in chronic kidney disease and its management.
Richard, William Whitehouse +3 more
openaire +2 more sources
Chronic kidney disease-mineral bone disorder
British Journal of Hospital Medicine, 2019Chronic kidney disease-mineral bone disorder is typically seen in patients with advanced chronic kidney disease. It is managed primarily by renal physicians, but non-renal physicians are also likely to encounter patients undergoing treatment for this condition in both inpatient and outpatient settings so a basic understanding of the principles may be ...
Thomas, Cronin +5 more
openaire +2 more sources
Management of Chronic Kidney Disease Mineral-Bone Disorder
Advances in Chronic Kidney Disease, 2007Chronic kidney disease mineral-bone disorder (CKD-MBD) is a systemic disorder of abnormal serum levels of mineral-related biochemistries, abnormal bone, and extraskeletal calcification. Although we have gained understanding on how these components are interrelated, our therapeutic tools remain focused on only one aspect of CKD-MBD at a time.
Stephen Z, Fadem, Sharon M, Moe
openaire +3 more sources
Pathophysiology of chronic kidney disease-mineral and bone disorder
Joint Bone Spine, 2012Chronic kidney disease (CKD) alters the metabolism of several minerals, thereby inducing bone lesions and vessel-wall calcifications that can cause functional impairments and excess mortality. The histological bone abnormalities seen in CKD, known as renal osteodystrophy, consist of alterations in the bone turnover rate, which may be increased ...
Mac Way, Fabrice +2 more
openaire +2 more sources
Calcimimetics in the Chronic Kidney Disease-Mineral and Bone Disorder
The International Journal of Artificial Organs, 2009Mineral and bone disorders (MBD) are both an early and very common complication of chronic kidney disease (CKD). It is now accepted that they represent a significant risk factor, explaining the high cardiovascular morbidity and mortality in CKD patients.
Jordi, Bover +11 more
openaire +2 more sources
Management of Chronic Kidney Disease–Mineral Bone Disorder
Orthopedics, 2010The cornerstone of management of chronic kidney disease-mineral bone disorder is to maintain normal bone turnover by maintaining adequate parathyroid hormone and vitamin D receptor agonism. Normalizing phosphorous, calcium, calcitriol, and parathyroid hormone levels is paramount.
Kathryn M, Ruf, Timothy, Clifford
openaire +2 more sources
Chronic Kidney Disease – Mineral Bone Disorder
Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis, 2008The definition, evaluation, and classification of the mineral abnormalities and bone disease in chronic kidney disease (CKD) should encompass all three clinical components: • Abnormalities in serum biochemistries • Vascular calcification • Bone abnormalities This principle was discussed at a Kidney Disease: Improving
openaire +1 more source
Chronic kidney disease-mineral and bone disorder
2015Abstract The kidneys play a critical role in maintaining normal serum calcium and phosphorus concentrations, under the regulation of three main hormones: parathyroid hormone, calcitriol, and fibroblast growth factor 23. With the progression of chronic kidney disease (CKD), most patients develop CKD–mineral and bone disorder (CKD-MBD ...
Stuart M. Sprague, Menaka Sarav
openaire +2 more sources
Sclerostin, Osteocytes, and Chronic Kidney Disease – Mineral Bone Disorder
Seminars in Dialysis, 2015AbstractOsteocytes respond to kidney damage by increasing production of secreted factors important to bone and mineral metabolism. These circulating proteins include the antianabolic factor, sclerostin, and the phosphaturic hormone, fibroblast growth factor 23 (FGF23).
Rosa M A, Moysés, Susan C, Schiavi
openaire +2 more sources